However, in esophageal squamous cell carcinoma, DSG2 expression showed no significant association with prognosis (Fang et al., 2014) and in ovarian serous carcinoma, Chen et al. (2018) reached the reverse conclusion that low expression of DSG2 was related to poor prognosis. Here, DSG2 is linked to ovarian serous carcinoma.